Clinical Trial Update: A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study of YL202 in combination with other anti-tumor therapies for patients with advanced solid tumors, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• YL202

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: Advanced Solid Tumors, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING